4.19 USD
▼-0.06-1.41%
盘后 4.17 -0.48%
2026-09-15
市值
$242.23M
市盈率
—
EPS
-2.18
股息率
—
52 周区间
2.20 – 7.75
成交量
175.27K
Beta
—
目标价
9.92
52W 低 2.2052W 高 7.75
价格走势
公司简介
Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-001, which is in a Phase 1/2 clinical trial for the treatment of urea cycle disorders. The company also develops CMP-002 for the treatment of SYNGAP1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018. The company was incorporated in 2015...